New Elite Feature: Chart Templates — Your indicators and design everywhere on Finviz

TScan Therapeutics, Inc.

Contributing Author

Recent Articles by TScan Therapeutics, Inc.

Mar-04	TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update TCRX GlobeNewswire
Feb-26	TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03 TCRX GlobeNewswire
Feb-25	TScan Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference TCRX +5.71% GlobeNewswire
Dec-06	TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition TCRX GlobeNewswire
Dec-03	TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA Phase 1 Trial and Future Market Opportunities TCRX +7.12% TCRX +6.86% GlobeNewswire
Nov-12	TScan Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update TCRX GlobeNewswire
Nov-05	TScan Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference TCRX GlobeNewswire
Nov-03	TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027 TCRX -36.08% GlobeNewswire
Sep-17	TScan Therapeutics Announces Upcoming Oral and Poster Presentations at the American College of Rheumatology Convergence 2025 TCRX -6.98% GlobeNewswire
Sep-03	TScan Therapeutics to Participate in Upcoming Investor Conferences TCRX +6.86% GlobeNewswire
Aug-12	TScan Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update TCRX GlobeNewswire
May-28	TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference TCRX GlobeNewswire
May-06	TScan Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update TCRX -9.33% GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)